NIH-funded research P01 program project

Personalized sleep apnea care using genetics and biomarkers

Official title: Developing a P4 Medicine Approach to Obstructive Sleep Apnea

Funded at University of Pennsylvania · NIH-11419810 · Data updated 2026-11-12

A patient-friendly look at a research program aiming to tailor sleep apnea care using genetics, biomarkers, and brain/body signals to improve prediction and prevention.

Quick facts

Grant typeP01 program project
Study typeNIH-funded research
Funding institutionUniversity of Pennsylvania
NIH-funded
Lab location1 site (Philadelphia, United States)
Project startJuly 1, 2023
Project endJune 30, 2028
Funding year2026
Award (this year)$2,365,421
NIH project number5P01HL160471-04
Project IDNIH-11419810 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates include adults at risk for or affected by obstructive sleep apnea who are willing to undergo genetic testing, imaging, and biomarker analysis.

Less likely to help

People without sleep apnea or those unwilling to participate in genetic and imaging studies may not directly benefit.

What this research studies

This NIH program bring together four projects and three support cores at the University of Pennsylvania to learn who is at risk for obstructive sleep apnea (OSA) and how best to prevent and personalize treatment. One project will map genetic factors and body structure around the airway to understand why some people develop OSA and how fat distribution, like tongue fat, affects risk. Another project will test microRNAs as biomarkers to reflect the disease and its response to challenges such as low oxygen during sleep. Researchers will use advanced imaging and machine learning to turn genetic and imaging data into a polygenic risk score that could one day guide personalized prevention and therapy. The work is designed to move precision medicine for OSA from discovery to practical tools that clinicians and patients can use.

Why it matters

Potential benefit: If successful, the program could lead to improved prediction of OSA risk and more personalized prevention and treatment strategies.

How similar studies have gone: Similar approaches using genetic data and biomarkers have shown promise in predicting OSA risk and tailoring therapies in some studies, but a full precision-medicine framework is still emerging.

Where this research is happening

  • University of Pennsylvania
    Philadelphia, United States
    Active

Researchers

  • Principal investigator: Pack, Allan I — University of Pennsylvania
  • Study coordinator: Pack, Allan I

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.